-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Scinai Immunotherapeutics Ltd. annual/quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2022 to Q2 2023.
- Scinai Immunotherapeutics Ltd. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 1.35B shares, a 81% increase year-over-year.
- Scinai Immunotherapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.56B shares, a 107% increase from 2022.
- Scinai Immunotherapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 754M shares, a 33.6% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)